What does CUSIP 74366E102 represent in this 13F holders report?

CUSIP 74366E102 is the security identifier for PTGX - Protagonist Therapeutics, Inc - Common Stock used to aggregate holder disclosures.

How many institutions held PTGX - Protagonist Therapeutics, Inc - Common Stock in Q1 2023?

135 institutional investors reported PTGX - Protagonist Therapeutics, Inc - Common Stock for Q1 2023. Use the holders table for investor-level position and value details.

Protagonist Therapeutics, Inc - Common Stock (PTGX)

CUSIP: 74366E102

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class: Equity / Common Stock
Shares outstanding: 63,850,747
Total 13F shares: 53,194,090
Share change: +4,316,387
Total reported value: $1,222,410,149
Put/Call ratio: 34%
Price per share: $23.00
Number of holders: 135
Value change: +$179,899,701
Number of buys: 76
Number of sells: 75

Quarterly Holders Quick Answers

What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2023
Previous quarter: Q4 2022

Recent filing periods for CUSIP 74366E102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
STATE STREET CORP	13F	Company	5.9%	3,792,926	$41,380,823	—	31 Dec 2022	13F
BlackRock Finance, Inc.	13F	Company	5.7%	3,652,157	$39,845,032	—	31 Dec 2022	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	5.7%	3,651,887	$39,842,087	—	31 Dec 2022	13F
RTW INVESTMENTS, LP	13F	Company	5.6%	3,591,986	$39,188,567	—	31 Dec 2022	13F
VANGUARD GROUP INC	13F	Company	4.9%	3,097,714	$33,796,060	—	31 Dec 2022	13F
JOHNSON & JOHNSON	13F	Company	3.8%	2,449,183	$26,721,000	—	31 Dec 2022	13F
MORGAN STANLEY	13F	Company	3.8%	2,438,517	$26,604,222	—	31 Dec 2022	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	3.7%	2,364,410	$25,796,000	—	31 Dec 2022	13F
CITADEL ADVISORS LLC	13F	Company	3.7%	2,355,314	$25,696,476	—	31 Dec 2022	13F
MARSHALL WACE, LLP	13F	Company	2.3%	1,454,446	$15,868,006	—	31 Dec 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	2.1%	1,345,389	$14,678,000	—	31 Dec 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.7%	1,077,226	$11,753,000	—	31 Dec 2022	13F
BRAIDWELL LP	13F	Company	1.5%	927,800	$10,122,298	—	31 Dec 2022	13F
DEUTSCHE BANK AG\	13F	Company	1.4%	925,662	$10,098,972	—	31 Dec 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	879,891	$9,599,000	—	31 Dec 2022	13F
Deep Track Capital, LP	13F	Company	1.4%	871,493	$9,507,989	—	31 Dec 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.2%	767,045	$8,368,461	—	31 Dec 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.97%	616,724	$6,728,459	—	31 Dec 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.95%	603,500	$6,584,185	—	31 Dec 2022	13F
Walleye Capital LLC	13F	Company	0.82%	524,302	$5,720,135	—	31 Dec 2022	13F
Kynam Capital Management, LP	13F	Company	0.82%	520,922	$5,683,259	—	31 Dec 2022	13F
Woodline Partners LP	13F	Company	0.8%	512,140	$5,587,447	—	31 Dec 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.77%	491,965	$5,367,338	—	31 Dec 2022	13F
Sio Capital Management, LLC	13F	Company	0.68%	434,635	$4,741,868	—	31 Dec 2022	13F
NORTHERN TRUST CORP	13F	Company	0.66%	418,607	$4,567,002	—	31 Dec 2022	13F
Madison Avenue Partners, LP	13F	Company	0.64%	406,593	$4,435,930	—	31 Dec 2022	13F
David Y. Liu	3/4/5	Chief R&D Strategy Officer	— class O/S missing	167,590	$4,127,742	—	16 Nov 2022	3/4/5
Nuveen Asset Management, LLC	13F	Company	0.56%	360,714	$3,936,000	—	31 Dec 2022	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.55%	350,133	$3,819,951	—	31 Dec 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.54%	344,947	$3,763,371	—	31 Dec 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.53%	340,021	$3,709,629	—	31 Dec 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.5%	316,500	$3,453,015	—	31 Dec 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.47%	303,162	$3,308,000	—	31 Dec 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.46%	295,348	$3,222,247	—	31 Dec 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.44%	284,115	$3,099,695	—	31 Dec 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.41%	258,867	$2,824,000	—	31 Dec 2022	13F
BARCLAYS PLC	13F	Company	0.4%	254,887	$2,780,817	—	31 Dec 2022	13F
SILVERCREST ASSET MANAGEMENT GROUP LLC	13F	Company	0.38%	240,745	$2,626,528	—	31 Dec 2022	13F
Soleus Capital Management, L.P.	13F	Company	0.37%	236,000	$2,574,760	—	31 Dec 2022	13F
UBS Group AG	13F	Company	0.35%	225,529	$2,460,521	—	31 Dec 2022	13F
Gratus Capital, LLC	13F	Company	0.34%	219,059	$2,389,934	—	31 Dec 2022	13F
683 Capital Management, LLC	13F	Company	0.33%	207,800	$2,267,098	—	31 Dec 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.31%	198,969	$2,170,750	—	31 Dec 2022	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.3%	194,704	$2,124,221	—	31 Dec 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.29%	188,036	$2,051,473	—	31 Dec 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.26%	167,369	$1,825,996	—	31 Dec 2022	13F
Bank of New York Mellon Corp	13F	Company	0.26%	164,325	$1,792,786	—	31 Dec 2022	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.24%	153,294	$1,672,440	—	31 Dec 2022	13F
NORGES BANK	13F	Company	0.23%	148,700	$1,622,317	—	31 Dec 2022	13F
CITIGROUP INC	13F	Company	0.23%	148,068	$1,615,422	—	31 Dec 2022	13F

Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q1 2023

As of 31 Mar 2023, Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by 135 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,194,090 shares. The largest 10 holders included RTW INVESTMENTS, LP, BlackRock Inc., BVF INC/IL, VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., JOHNSON & JOHNSON, STATE STREET CORP, Cormorant Asset Management, LP, and MORGAN STANLEY. This page lists 136 institutional shareholders reporting positions in this security for the Q1 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders

135

Q1 2023 holders

135

Holder diff

Investor	Q4 2022 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q4 2022 Value $	Q1 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.